Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander S Hauser

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Neurochemistry International|December 6, 2016
The orphan G protein-coupled receptor GPR139 is activated by the peptides: Adrenocorticotropic hormone (ACTH), α-, and β-melanocyte stimulating hormone (α-MSH, and β-MSH), and the conserved core motif HFRWAnne Cathrine Nøhr, Mohamed A Shehata, Alexander S Hauser, et al.
The Journal of Biological Chemistry|November 21, 2021
Molecular and in vivo phenotyping of missense variants of the human glucagon receptorWijnand J C van der Velden, Peter Lindquist, Jakob S Madsen, et al.
Science Advances|March 14, 2025
The sodium leak channel NALCN is regulated by neuronal SNARE complex proteinsSamuel Usher, Estelle Toulmé, Roberta Florea, et al.
Cell|November 2, 2019
Discovery of Human Signaling Systems: Pairing Peptides to G Protein-Coupled ReceptorsSimon R Foster, Alexander S Hauser, Line Vedel, et al.
Nature Communications|October 9, 2023
GLP-1R signaling neighborhoods associate with the susceptibility to adverse drug reactions of incretin mimeticsShane C Wright, Aikaterini Motso, Stefania Koutsilieri, et al.
British Journal of Pharmacology|May 30, 2025
Biodiversity2Drugs-Renaissance of exploring nature-derived peptides for GPCR ligand discoveryChristian W Gruber, Isabel Beets, Pierre-Luc Boudreault, et al.
The Journal of Clinical Endocrinology and Metabolism|May 26, 2023
Rare Heterozygous Loss-of-Function Variants in the Human GLP-1 Receptor Are Not Associated With Cardiometabolic PhenotypesJosefine U Melchiorsen, Kimmie V Sørensen, Jette Bork-Jensen, et al.
Elife|March 18, 2022
Effector membrane translocation biosensors reveal G protein and βarrestin coupling profiles of 100 therapeutically relevant GPCRsCharlotte Avet, Arturo Mancini, Billy Breton, et al.
Neuron|July 19, 2025
The polypharmacology of psychedelics reveals multiple targets for potential therapeuticsManish K Jain, Ryan H Gumpper, Samuel T Slocum, et al.
Nature Metabolism|June 13, 2024
Characterization of genetic variants of GIPR reveals a contribution of β-arrestin to metabolic phenotypesHüsün S Kizilkaya, Kimmie V Sørensen, Jakob S Madsen, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Neurochemistry International|December 6, 2016
The orphan G protein-coupled receptor GPR139 is activated by the peptides: Adrenocorticotropic hormone (ACTH), α-, and β-melanocyte stimulating hormone (α-MSH, and β-MSH), and the conserved core motif HFRWAnne Cathrine Nøhr, Mohamed A Shehata, Alexander S Hauser, et al.
The Journal of Biological Chemistry|November 21, 2021
Molecular and in vivo phenotyping of missense variants of the human glucagon receptorWijnand J C van der Velden, Peter Lindquist, Jakob S Madsen, et al.
Science Advances|March 14, 2025
The sodium leak channel NALCN is regulated by neuronal SNARE complex proteinsSamuel Usher, Estelle Toulmé, Roberta Florea, et al.
Cell|November 2, 2019
Discovery of Human Signaling Systems: Pairing Peptides to G Protein-Coupled ReceptorsSimon R Foster, Alexander S Hauser, Line Vedel, et al.
Nature Communications|October 9, 2023
GLP-1R signaling neighborhoods associate with the susceptibility to adverse drug reactions of incretin mimeticsShane C Wright, Aikaterini Motso, Stefania Koutsilieri, et al.
British Journal of Pharmacology|May 30, 2025
Biodiversity2Drugs-Renaissance of exploring nature-derived peptides for GPCR ligand discoveryChristian W Gruber, Isabel Beets, Pierre-Luc Boudreault, et al.
The Journal of Clinical Endocrinology and Metabolism|May 26, 2023
Rare Heterozygous Loss-of-Function Variants in the Human GLP-1 Receptor Are Not Associated With Cardiometabolic PhenotypesJosefine U Melchiorsen, Kimmie V Sørensen, Jette Bork-Jensen, et al.
Elife|March 18, 2022
Effector membrane translocation biosensors reveal G protein and βarrestin coupling profiles of 100 therapeutically relevant GPCRsCharlotte Avet, Arturo Mancini, Billy Breton, et al.
Neuron|July 19, 2025
The polypharmacology of psychedelics reveals multiple targets for potential therapeuticsManish K Jain, Ryan H Gumpper, Samuel T Slocum, et al.
Nature Metabolism|June 13, 2024
Characterization of genetic variants of GIPR reveals a contribution of β-arrestin to metabolic phenotypesHüsün S Kizilkaya, Kimmie V Sørensen, Jakob S Madsen, et al.
Pageof 4